6N05
Structure of anti-crispr protein, AcrIIC2
Summary for 6N05
Entry DOI | 10.2210/pdb6n05/pdb |
Descriptor | AcrIIC2 (2 entities in total) |
Functional Keywords | prophage protein. anti-crispr, viral protein |
Biological source | Neisseria meningitidis |
Total number of polymer chains | 2 |
Total formula weight | 36490.35 |
Authors | Shah, M.,Thavalingham, A.,Maxwell, K.L.,Moraes, T.F. (deposition date: 2018-11-06, release date: 2019-06-05, Last modification date: 2024-10-23) |
Primary citation | Thavalingam, A.,Cheng, Z.,Garcia, B.,Huang, X.,Shah, M.,Sun, W.,Wang, M.,Harrington, L.,Hwang, S.,Hidalgo-Reyes, Y.,Sontheimer, E.J.,Doudna, J.,Davidson, A.R.,Moraes, T.F.,Wang, Y.,Maxwell, K.L. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2. Nat Commun, 10:2806-2806, 2019 Cited by PubMed Abstract: CRISPR-Cas adaptive immune systems function to protect bacteria from invasion by foreign genetic elements. The CRISPR-Cas9 system has been widely adopted as a powerful genome-editing tool, and phage-encoded inhibitors, known as anti-CRISPRs, offer a means of regulating its activity. Here, we report the crystal structures of anti-CRISPR protein AcrIIC2 alone and in complex with Nme1Cas9. We demonstrate that AcrIIC2 inhibits Cas9 through interactions with the positively charged bridge helix, thereby preventing sgRNA loading. In vivo phage plaque assays and in vitro DNA cleavage assays show that AcrIIC2 mediates its activity through a large electronegative surface. This work shows that anti-CRISPR activity can be mediated through the inhibition of Cas9 complex assembly. PubMed: 31243272DOI: 10.1038/s41467-019-10577-3 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report
